When is iron overload deleterious, and when and how should iron chelation therapy be administered in myelodysplastic syndromes?

Title
When is iron overload deleterious, and when and how should iron chelation therapy be administered in myelodysplastic syndromes?
Authors
Keywords
-
Journal
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
Volume 26, Issue 4, Pages 431-444
Publisher
Elsevier BV
Online
2013-10-02
DOI
10.1016/j.beha.2013.09.009

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation